Efficacy of Tramadol With Levobupivacaine for Modified Pectoral Nerve Block
NCT ID: NCT02625506
Last Updated: 2020-09-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2012-06-01
2016-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Does Local Morphine Add to Local Anesthetics in Serratus Anterior Plane Block Has a System Analgesic Effect?
NCT02962024
Effect of Morphine, Tramadol, and Ketorolac on Postoperative Stress and Immune Responses
NCT02449954
Efficacy of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain
NCT02620371
Infusion of Dexmedetomidine Versus Lidocaine in Management of Acute Postoperative Pain After Modified Radical Mastectomy
NCT06974656
Intraoperative Pectoral Block vs IV Analgesia for Pain After Modified Radical Mastectomy
NCT07257874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Pecs block is less invasive procedure involving ultrasound guided inter-fascial injections which has been suggested as potential alternative analgesic technique.
The block produces excellent analgesia and can be used as a rescue block in cases where the analgesia provided by the paravertebral or epidural was patchy or ineffective .
Different drugs, including opioids, non-steroidal anti-inflammatory drugs, ketamine, clonidine, and neostigmine, have been added to local anesthetics to improve the duration and quality of analgesia.Tramadol has also been used for pain management of patients.
The power of this clinical trial was prospectively calculated using the G Power analysis program. Using a priory power analysis with accuracy mode calculations with visual analogue score (VAS) as the primary variant and assuming type I error protection of 0.05 and an effect size convention of 0.9, a total sample size of 54 patients (27 patients in each group) produced a power of 0.90. To protect against drop out cases we added 6 cases to the total number (total of 60 cases)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Levobupivacaine
Patients will be subjected for radical mastectomy surgery and pectoral nerve block with levobupivacaine
Levobupivacaine
Ultrasound guided Pecs block will be performed using 20 ml of levobupivacaine
Levobupivacaine and Tramadol
Patients will be subjected for radical mastectomy surgery and pectoral nerve block with levobupivacaine and tramadol
Levobupivacaine and Tramadol
Ultrasound guided Pecs block will be performed using 20 ml of levobupivacaine in conjunction with tramadol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Levobupivacaine
Ultrasound guided Pecs block will be performed using 20 ml of levobupivacaine
Levobupivacaine and Tramadol
Ultrasound guided Pecs block will be performed using 20 ml of levobupivacaine in conjunction with tramadol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients scheduled for radical mastectomy surgery.
Exclusion Criteria
* renal diseases
* Hepatic diseases
* Endocrinal diseases.
* Pregnancy
* Postpartum
* Lactating females
* Allergy to study medications.
* Local skin infection
* Bleeding disorder
* Coagulation abnormality
* Spine deformity
* chest deformity
* Psychiatric disease
20 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mansoura University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Salwa MS Hayes, MD
Role: PRINCIPAL_INVESTIGATOR
Assistant Professor of Anesthesia and Surgical Intensive Care
Reem A Sharkawy, MD
Role: STUDY_DIRECTOR
Lecture of Anesthesia and Surgical Intensive Care
Tamer EM Farahat, MD
Role: STUDY_CHAIR
Lecture of Anesthesia and Surgical Intensive Care
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mansoura University, Mansoura Oncology Center
Al Mansurah, DK, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R/15.05.67
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.